Sökning: onr:"swepub:oai:DiVA.org:uu-472740" > Expression of PD-1,...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04527naa a2200445 4500 | |
001 | oai:DiVA.org:uu-472740 | |
003 | SwePub | |
008 | 220419s2022 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4727402 URI |
024 | 7 | a https://doi.org/10.3390/cancers140615092 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Hellbacher, Eriku Uppsala universitet,Reumatologi4 aut0 (Swepub:uu)erihe902 |
245 | 1 0 | a Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity |
264 | c 2022-03-15 | |
264 | 1 | b MDPI,c 2022 |
338 | a electronic2 rdacarrier | |
520 | a Simple Summary Immunotherapy blocking programmed cell death protein 1 (PD-1) and its ligands (PD-L1, PD-L2) is less effective in non-Hodgkin lymphoma (NHL) than classical Hodgkin lymphoma. However, NHL is a heterogeneous group and current research seeks to identify subgroups of NHL patients responsive to PD-1 blocking agents. Whether patients with pre-existing rheumatic diseases might constitute such a subgroup is unknown. We investigated the expression of PD-1 and its ligands in lymphoma patients with pre-existing rheumatic diseases. Our key findings include that in patients with pre-existing rheumatoid arthritis (RA) and subsequent diffuse large B-cell lymphoma, an association between RA disease severity and increased expression of PD-L1 in tumor cells was seen. This warrants further studies of the PD-1 pathway in lymphoma in other chronic inflammatory conditions. Current research seeks to identify subgroups of non-Hodgkin lymphoma (NHL) patients responsive to PD-1 blocking agents. Whether patients with pre-existing rheumatic diseases might constitute such a subgroup is unknown. We determined intratumoral expression of PD-1 and its ligands in lymphoma patients with pre-existing rheumatic diseases. We included 215 patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or Sjogren's syndrome with subsequent lymphoma and 74 diffuse large B-cell lymphoma (DLBCL) controls without rheumatic disease. PD-1 and PD-ligand immunohistochemical markers were applied on tumor tissue microarrays. The number of PD-1+ tumor infiltrating leukocytes (TILs) and proportions of PD-L1+ and PD-L2+ tumor cells and TILs were calculated and correlated with clinical data. Expression of PD-L1 in tumor cells and TILs was highest in classical Hodgkin lymphoma and DLBCL. In DLBCLs, expression of PD-1 in TILs and PD-L1 in tumor cells was similar in RA, SLE and controls. In RA-DLBCL, high expression of PD-L1 in tumor cells was significantly more common in patients with the most severe RA disease and was associated with inferior overall survival in multivariable analysis. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a lymphoma | |
653 | a PD-1 | |
653 | a PD-L1 | |
653 | a rheumatic disease | |
653 | a immunohistochemistry | |
700 | 1 | a Sundström, Christeru Uppsala universitet,Experimentell och klinisk onkologi,Klinisk och experimentell patologi,Science for Life Laboratory, SciLifeLab4 aut0 (Swepub:uu)chrisund |
700 | 1 | a Molin, Daniel,d 1969-u Uppsala universitet,Experimentell och klinisk onkologi4 aut0 (Swepub:uu)danimoli |
700 | 1 | a Baecklund, Eva,d 1956-u Uppsala universitet,Reumatologi,Science for Life Laboratory, SciLifeLab4 aut0 (Swepub:uu)evaba786 |
700 | 1 | a Hollander, Peteru Uppsala universitet,Experimentell och klinisk onkologi,Klinisk och experimentell patologi4 aut0 (Swepub:uu)petho189 |
710 | 2 | a Uppsala universitetb Reumatologi4 org |
773 | 0 | t Cancersd : MDPIg 14:6q 14:6x 2072-6694 |
856 | 4 | u https://doi.org/10.3390/cancers14061509y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1652665/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-472740 |
856 | 4 8 | u https://doi.org/10.3390/cancers14061509 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy